Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study.
- Resource Type
- Letter to the Editor
- Authors
- Chaoui, Driss; Leprêtre, Stéphane; Liu, Kun Lun; Barry, Marly; Tempescul, Adrian; Dilhuydy, Marie-Sarah; Chaib, Abdelaziz; Slama, Borhane; Labourey, Jean Luc; Benbrahim, Omar; Dreyfus, Brigitte; Hacini, Maya; Mahé, Béatrice; Maynadié, Marc; Delmer, Alain; Benkanoun, Chahinez; Boissard, Frédéric; Gandon, Sophie; Veerabudun, Kalaivani; Choquet, Sylvain
- Source
- Leukemia & Lymphoma. Jun2019, Vol. 60 Issue 6, p1563-1567. 5p.
- Subject
- *CHRONIC lymphocytic leukemia
*PROGRESSION-free survival
- Language
- ISSN
- 1042-8194